# Single-dose Study in Two Panels of Healthy Adult Participants to Assess Immediate-Release and Dispersible Formulations of Pretomanid

> **NCT04309656** · PHASE1 · COMPLETED · sponsor: **Global Alliance for TB Drug Development** · enrollment: 48 (actual)

## Conditions studied

- Multi-drug Resistant Tuberculosis

## Interventions

- **DRUG:** Pretomanid

## Key facts

- **NCT ID:** NCT04309656
- **Lead sponsor:** Global Alliance for TB Drug Development
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-14
- **Primary completion:** 2020-02-28
- **Final completion:** 2020-02-28
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2024-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04309656

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04309656, "Single-dose Study in Two Panels of Healthy Adult Participants to Assess Immediate-Release and Dispersible Formulations of Pretomanid". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04309656. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*